Rewriting Biotech Discovery, Validation and Scale
- What does an AI-first R&D pipeline look like, and how are language models and predictive platforms using large biological datasets to surface new microbes, proteins, molecules, and genetic traits?
- Which differentiated modes of action are showing the strongest commercial promise, and how are new biologicals and genetic innovations delivering measurable agronomic and economic value?
- How are early-stage discoveries validated with scientific rigor, and what is the emerging role of agentic AI in autonomously designing experiments, prioritizing targets, and accelerating validation?
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)